Why the study?
Does perioperative medical optimization or prophylactic revascularization improve outcomes in patients with coronary artery disease undergoing major non-cardiac surgery?
Population
Patients with coronary artery disease undergoing major non-cardiac surgery
Design
Editorial
Authors
Loading...
Optimizing medical treatment, particularly with beta-blockers, is likely the best option for most patients with coronary artery disease undergoing major non-cardiac surgery, reserving prophylactic revascularization for a well-defined minority.
Does perioperative medical optimization or prophylactic revascularization improve outcomes in patients with coronary artery disease undergoing major non-cardiac surgery?
Optimizing medical treatment, particularly with beta-blockers, is likely the best option for most patients with coronary artery disease undergoing major non-cardiac surgery, reserving prophylactic revascularization for a well-defined minority.
Sonksen et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: